Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Grossman currently holds 4,008 shares of AIT Therapeutics, Inc. (AITB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Grossman has been a net neutral trader of AITB stock. They have purchased $0 and sold $0 worth of shares.
David Grossman's most recent insider trade was on Feb 16, 2018, when they sold 2,342 shares at $4.25 per share.
David Grossman serves as Executive at AIT Therapeutics, Inc. (AITB). They have executed 1 insider transactions totaling $0 over their tenure at the company.
David Grossman holds the position of Executive at AIT Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
David Grossman has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by David Grossman was on Feb 16, 2018, when they sold $10.0K worth of AITB shares. This transaction involved 2,342 shares at $4.25 per share.
David Grossman currently owns 4,008 shares of AIT Therapeutics, Inc. (AITB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Grossman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Grossman has 1 Form 4 filings on record as an insider at AIT Therapeutics, Inc..
Set alerts for David Grossman and 40,000+ other insiders.